This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
Unilateral or bilateral intraocular retinoblastoma
Diagnosis between the ages of 0 - 17.99 years
Diagnosis on or after January 1, 2008
No exclusions based on primary or secondary treatment modalities
None
Vanderbilt-Ingram Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator